Publisher: APO Research, Inc.
Category: Biologics

Biologics market research reports by APO Research, Inc.

(8 reports matching your criteria)
    • Global Biologics and Biosimilars Industry Growth and Trends Forecast to 2031

      Summary According to APO Research, The global Biologics and Biosimilars market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031. North American market for Biologics and Biosimilars is e ... Read More

    • Global Biologics and Biosimilars Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

      Summary According to APO Research, The global Biologics and Biosimilars market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. The US & Canada market for Biologics and Biosimilars is estimated to increase ... Read More

    • Biologics and Biosimilars Industry Research Report 2025

      Summary According to APO Research, The global Biologics and Biosimilars market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031. North American market for Biologics and Biosimilars is estimated to increas ... Read More

    • Biologics and Biosimilars Industry Research Report 2024

      Biologics and Biosimilars Industry Research Report 2024 Summary A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report i ... Read More

    • Global Biologics and Biosimilars Market Analysis and Forecast 2024-2030

      Global Biologics and Biosimilars Market Analysis and Forecast 2024-2030 Summary A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. ... Read More

    • Global Biologics and Biosimilars Market Size, Manufacturers, Opportunities and Forecast to 2030

      Global Biologics and Biosimilars Market Size, Manufacturers, Opportunities and Forecast to 2030 Summary A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from gene ... Read More

    • Global Biologics and Biosimilars Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030

      Global Biologics and Biosimilars Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030 Summary A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived fr ... Read More

    • Global Biologics and Biosimilars Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030

      Global Biologics and Biosimilars Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030 Summary A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or protei ... Read More

Research Assistance

Live help

Join Alert Me Now!

Sign Up

Find out more on our blog
Cookie Settings